Memphasys scheduled to complete clinical trial “by the end of the calendar year”
Clinical trials of its Felix sperm separation device for IVF clinics are now 90 per cent complete, according to reproductive technology specialist Memphasys, with the company also sharing that it now anticipates “entering larger markets earlier than previously expected” following a decision to pursue CE mark registration. In a statement on Thursday, the company told…